Chardan Capital Markets Starts BioTime, Inc. (BTX) at Buy

February 19, 2016 7:34 AM EST Send to a Friend
Chardan Capital Markets initiates coverage on BioTime, Inc. (NYSE: BTX) with a Buy rating and a price target of $5.00.Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login